Pancreatic Cancer Research

ResearcherHarvard UniversityNo recent work listed

Jochen K. Lennerz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2434-4978; OpenAlex author ID A5067299042. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 3 papers

Papers 5

  1. Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition. Co-author DOI 10.1038/ncomms8677↗
  2. Allelic Ratio of KRAS Mutations in Pancreatic Cancer Co-author DOI 10.1634/theoncologist.2014-0408↗
  3. GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinoma. Last author DOI 10.18632/oncotarget.2799↗
  4. Jaundice in resected pancreatic cancer patients. First author DOI 10.1111/hpb.12158↗
  5. Absence of FLICE-inhibitory protein is a novel independent prognostic marker for very short survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e31829655ed↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fenja M Feld · 3 shared papers, 2014–2015 · strength 0.18
  2. Albrecht Stenzinger · 2 shared papers, 2015 · strength 0.16
  3. Peter Möller · 2 shared papers, 2013–2015 · strength 0.09
  4. Alexander Kleger · 2 shared papers, 2013–2015 · strength 0.08
  5. Ronan Russell · 1 shared paper, 2015 · strength 0.04
  6. Jochen Gaedcke · 1 shared paper, 2015 · strength 0.04
  7. Thomas Theodor Werner Seufferlein · 1 shared paper, 2015 · strength 0.04
  8. Elisabeth Heßmann · 1 shared paper, 2015 · strength 0.04
  9. Guido von Figura · 1 shared paper, 2015 · strength 0.04
  10. Lukas Perkhofer · 1 shared paper, 2015 · strength 0.04
  11. Sandra J Schmid · 1 shared paper, 2013 · strength 0.04
  12. Simone Fulda · 1 shared paper, 2013 · strength 0.04
  13. Marko Kornmann · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.